Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genoss
South Koreagenoss.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Genoss has commercialized multiple medical device products globally. Its Monalisa hyaluronic acid filler line has demonstrated safety and efficacy in aesthetic indications with at least one multicenter clinical study comparing it to leading competitors. The company’s sirolimus-eluting coronary stent system ("GENOSS DES") and OSFIT Drug-Eluting Stent are currently being evaluated in prospective multicenter clinical trials targeting patients with multivessel coronary artery disease or ostial lesions. The company also markets FDA/CE-approved orthopedic implants and dental materials.
- Therapeutic areas
- DermatologyCardiovascularOther
- Modalities
- Device (including medical devices for aesthetics and interventional cardiology)Biologic (hyaluronic acid-based fillers)Small molecule (possible in drug-eluting stents)Biomaterial (bone grafts and orthopedic implants)
- Industry
- Implantable Medical Devices
02
Partnerships
No major pharmaceutical partnerships disclosed; distributed in over forty countries through local partners/distributors.
Beyond the preview
Go deeper on Genoss.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genoss.